amtagvi

Generic: lifileucel

Labeler: iovance biotherapeutics inc.
NDC Directory CELLULAR THERAPY BLA Inactive Finished

Drug Facts

Product Profile

Brand Name amtagvi
Generic Name lifileucel
Labeler iovance biotherapeutics inc.
Dosage Form SUSPENSION
Routes
INTRAVENOUS
Active Ingredients

lifileucel 72000000000 1/500mL

Manufacturer
Iovance Biotherapeutics Inc.

Identifiers & Regulatory

Product NDC 73776-001
Product ID 73776-001_4120d6b2-93d7-e0bf-e063-6294a90a6e7f
Product Type CELLULAR THERAPY
Marketing Category BLA
Application Number BLA125773
Listing Expiration 2026-12-31
Marketing Start 2024-02-16

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 73776001
Hyphenated Format 73776-001

Supplemental Identifiers

RxCUI
2675868 2675874
UPC
0373776001121
UNII
R0835E18NH

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amtagvi (source: ndc)
Generic Name lifileucel (source: ndc)
Application Number BLA125773 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 72000000000 1/500mL
source: ndc
Packaging
  • 1 BAG in 1 CARTRIDGE (73776-001-12) / 125 mL in 1 BAG (73776-001-11)
source: ndc

Packages (1)

73776-001-12 1 BAG in 1 CARTRIDGE (73776-001-12) / 125 mL in 1 BAG (73776-001-11)

Ingredients (1)

lifileucel (72000000000 1/500mL)

Linked Drug Pages (1)

AMTAGVI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4120d6b2-93d7-e0bf-e063-6294a90a6e7f", "openfda": {"upc": ["0373776001121"], "unii": ["R0835E18NH"], "rxcui": ["2675868", "2675874"], "spl_set_id": ["4121bd3f-2d6e-3bdd-e063-6294a90a3088"], "manufacturer_name": ["Iovance Biotherapeutics Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BAG in 1 CARTRIDGE (73776-001-12)  / 125 mL in 1 BAG (73776-001-11)", "package_ndc": "73776-001-12", "marketing_start_date": "20240216"}], "brand_name": "AMTAGVI", "product_id": "73776-001_4120d6b2-93d7-e0bf-e063-6294a90a6e7f", "dosage_form": "SUSPENSION", "product_ndc": "73776-001", "generic_name": "lifileucel", "labeler_name": "Iovance Biotherapeutics Inc.", "product_type": "CELLULAR THERAPY", "brand_name_base": "AMTAGVI", "active_ingredients": [{"name": "LIFILEUCEL", "strength": "72000000000 1/500mL"}], "application_number": "BLA125773", "marketing_category": "BLA", "marketing_start_date": "20240216", "listing_expiration_date": "20261231"}